SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-045172
Filing Date
2024-05-20
Accepted
2024-05-20 16:05:48
Documents
91
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0206102-10q_onconetix.htm   iXBRL 10-Q 1039610
2 CERTIFICATION ea020610201ex31-1_onconetix.htm EX-31.1 12070
3 CERTIFICATION ea020610201ex31-2_onconetix.htm EX-31.2 11753
4 CERTIFICATION ea020610201ex32-1_onconetix.htm EX-32.1 4543
5 CERTIFICATION ea020610201ex32-2_onconetix.htm EX-32.2 4653
  Complete submission text file 0001213900-24-045172.txt   7340196

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bwv-20240331.xsd EX-101.SCH 80951
7 XBRL CALCULATION FILE bwv-20240331_cal.xml EX-101.CAL 75444
8 XBRL DEFINITION FILE bwv-20240331_def.xml EX-101.DEF 419034
9 XBRL LABEL FILE bwv-20240331_lab.xml EX-101.LAB 731793
10 XBRL PRESENTATION FILE bwv-20240331_pre.xml EX-101.PRE 419330
95 EXTRACTED XBRL INSTANCE DOCUMENT ea0206102-10q_onconetix_htm.xml XML 688372
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41294 | Film No.: 24964409
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)